Viewing Study NCT05498220


Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2025-12-26 @ 3:03 AM
Study NCT ID: NCT05498220
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-02
First Post: 2022-08-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma
Sponsor: UNC Lineberger Comprehensive Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module